Nicotine and Behavior in Adult ADHD
NCT00573248 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 78
Last updated 2011-09-09
Summary
Attention deficit hyperactivity disorder (ADHD) is characterized by inattention, impulsivity, and hyperactivity that are frequently treated with stimulant medications such as Ritalin. Many people with ADHD smoke. The smoking prevalence rates are estimated to be 40% in adults with ADHD compared to 20% in the general population. People with ADHD have also more difficulty to quit smoking. Only 29% of smokers with ADHD quit smoking compared to 48.5% of smokers in the general population. Nicotine is a stimulant, which may have properties similar to stimulant medications (e.g., Ritalin) used to treat ADHD. Nicotine may increase attention and reduce hyperactivity and impulsivity and, thus, may regulate behavior in individuals with ADHD. Alleviating the symptoms of ADHD and increasing cardiovascular activity through smoking may mimic the effects of stimulant medications and can be a form of self-medication.
The major objective of the study was to examine the effects of nicotine on ADHD symptoms, moods, and cardiovascular activity. The study investigated the effects of nicotine patches on behavioral regulation in adult smokers and nonsmokers with ADHD. Smokers and nonsmokers with ADHD participated in two conditions: (1) nicotine patch and (2) placebo patch. During each condition, symptoms, moods, and side effects were assessed for 2 days during waking hours. An electronic handheld diary, programmed to prompt the participant twice per hour, recorded ADHD symptoms (e.g., difficulty concentrating, impulsivity, etc.), negative moods (e.g., anger, stress), and nicotine side effects (nausea, dizziness). Heart rate and blood pressure were recorded with lightweight ambulatory monitors to indicate cardiovascular activity. Results provided information about the effects of nicotine patches on behavioral regulation in adult smokers and nonsmokers with ADHD.
The inclusion of nonsmokers was important to clarify whether the effects of nicotine on smokers was due to smoking withdrawal. The findings help explain the increased smoking prevalence rates and reduced quit rates associated with ADHD. Knowledge about nicotine's effects on behavioral regulation can help to develop successful smoking cessation programs for individuals with ADHD. The findings on cardiovascular activity may help determine the potential risk for cardiovascular disease in smokers and nonsmokers with ADHD. The study contributed to understanding nicotine's effects on behavioral regulation in a highly vulnerable population such as people with ADHD.
Conditions
- ADHD
Interventions
- DRUG
-
Nicotine
21 mg nicotine patches for smokers for 2 days 7 mg nicotine patches for nonsmokers for 2 days
- OTHER
-
Placebo
Placebo Patch
Sponsors & Collaborators
-
University of California, Irvine
lead OTHER
Principal Investigators
-
Jean G Gehricke, Ph.D. · University of California, Irvine
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-08-31
- Primary Completion
- 2009-12-31
- Completion
- 2009-12-31
Countries
- United States
Study Locations
More Related Trials
-
Nicotine Withdrawal Symptoms and Smoking Relapse
NCT01511614 ·Status: COMPLETED ·Phase: NA
-
Attention Deficit Hyperactivity Disorder (ADHD) Smoking Cessation Study
NCT00736255 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Bupropion for Treatment of Adolescent Smoking
NCT00248118 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Chantix in Adult Smokers With Attention Deficit Hyperactivity Disorder (ADHD)
NCT00907218 ·Status: TERMINATED ·Phase: PHASE4
-
Nicotine Replacement Therapy (NRT) and Bupropion Mechanisms of Effectiveness in Smokers
NCT01048944 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Smoking Exposure on Smoking Relapse Following Brief Abstinence - 2
NCT00136838 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Bupropion for Treating Nicotine Dependence in Young People
NCT00129272 ·Status: COMPLETED ·Phase: PHASE2
-
Bupropion as an Adjunct to the Nicotine Patch Plus CBT
NCT00142831 ·Status: COMPLETED ·Phase: PHASE4
-
Supplemental Nicotine Administration for Smoking Cessation in Posttraumatic Stress Disorder (PTSD)
NCT01055886 ·Status: COMPLETED ·Phase: NA
-
Safety of Combining Modafinil and Nicotine Replacement Therapy in Treating Nicotine Dependent Adolescents
NCT00258479 ·Status: COMPLETED ·Phase: PHASE1
-
The Effects of Memantine and Bupropion on Acute, Reinforcing, and Conditioned Effects of Cigarettes - 1
NCT00136747 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness of Combined Tobacco Treatment in Hospitalized Subjects
NCT06254001 ·Status: RECRUITING ·Phase: PHASE4
-
Effectiveness of Various Smoking Cessation Therapies in Reducing Smoking in Adolescents - 1
NCT00158171 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People With Schizophrenia
NCT00218218 ·Status: COMPLETED ·Phase: PHASE2
-
Beta-Adrenergic Modulation of Drug Cue Reactivity
NCT05587361 ·Status: RECRUITING ·Phase: PHASE4
-
Smoking Relapse Prevention in Schizophrenia
NCT00320697 ·Status: COMPLETED ·Phase: PHASE4
-
Addictive Threshold of Nicotine
NCT06096714 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Bupropion and Cigarette-Related Cues in Smokers
NCT03920319 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment With Mecamylamine in Smoking and Non-smoking Alcohol Dependent Patients
NCT00342563 ·Status: COMPLETED ·Phase: PHASE2
-
Smoking Cessation Medications: Efficacy, Mechanisms and Algorithms
NCT00332644 ·Status: COMPLETED ·Phase: PHASE4
-
The Use of AVL-3288 to Potentiate the Attention-Enhancing Effects of Low-Dose Nicotine
NCT03281694 ·Status: WITHDRAWN ·Phase: PHASE1
-
Nicotine Patch Pretreatment for Smoking Cessation in PTSD
NCT00625131 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effect Of Nicotine on Neurocognitive Performance of Cigarette Smokers
NCT00429208 ·Status: UNKNOWN ·Phase: NA
-
Combined Pharmaco/Behavior Therapy in Adolescent Smokers
NCT00330187 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Nicotine on Brain Activity as Measured by fMRI
NCT01037153 ·Status: COMPLETED